Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Monovisc (sodium hyaluronate) for the Treatment of Osteoarthritis

Drug Name (Brand / Generic)

Monovisc / sodium hyaluronate

Developed by

Anika Therapeutics

Product Description

A sterile, non-pyrogenic, viscoelastic solution of hyaluronan

Current Indication

Osteoarthritis

Market Sector

Rheumatology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top